Legal & General Group
PASG icon

Legal & General Group’s Passage Bio PASG Stock Holding History

Legal & General Group’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-148
Closed -$7K – 3477
2022
Q2 		$7K Sell
148
-265
-64% -$12.4K ﹤0.01% 3415
2022
Q1 		$26K Hold
413
– – ﹤0.01% 3163
2021
Q4 		$53K Hold
413
– – ﹤0.01% 3020
2021
Q3 		$82K Buy
413
+236
+133% +$56.3K ﹤0.01% 2891
2021
Q2 		$47K Sell
177
-20
-10% -$6.19K ﹤0.01% 2968
2021
Q1 		$68K Buy
197
+39
+25% +$16.7K ﹤0.01% 2735
2020
Q4 		$81K Buy
158
+53
+50% +$21.2K ﹤0.01% 2644
2020
Q3 		$28K Sell
105
-27
-20% -$9.29K ﹤0.01% 2872
2020
Q2 		$72K Buy
+132
New +$59.4K ﹤0.01% 2618

Other funds holding PASG

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Legal & General Group's PASG Position: Q3 2022 in Review

Legal & General Group sold out of Passage Bio (PASG) in Q3 2022, closing a stake of 148 shares — an estimated $7K sold.

Legal & General Group first reported a position in PASG in Q2 2020 and held it in 9 quarters. The position peaked at $82K in Q3 2021. 75 funds tracked by Wall St. Rank hold PASG as of Q3 2022.

  • Legal & General Group reported no remaining Passage Bio position as of Q3 2022 after selling out during the quarter.
  • Legal & General Group sold 148 Passage Bio shares in Q3 2022, an estimated $7K.
  • Legal & General Group first reported a position in Passage Bio in Q2 2020 and held it in 9 quarters.
  • Legal & General Group's Passage Bio position peaked at $82K in Q3 2021.
  • 75 funds tracked by Wall St. Rank held Passage Bio as of Q3 2022.

Based on Legal & General Group's 13F filing for Q3 2022, filed 14 Nov 2022.